Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India

References

• BaladyGJWilliamsMAAdesPACore components of cardiac rehabilitation/secondary prevention programs: 2007 updateCirculation20071152675268217513578
   PubMed Web of Science ®Google Scholar
• FoxKStable angina pectorisCompendium of Abridged ESC GuidelinesNice, FranceEuropean Society of Cardiology20087789
   Google Scholar
• National Institute of Clinical Excellence CG48MI: Secondary prevention: understanding NICE guidelines Available at: http://www.nice.org.uk/nicemedia/pdf/CG48PublicInfo.pdf
   Google Scholar
• World Health OrganisationWellcome Trust Meeting Report Secondary prevention of noncommunicable diseases in low and middle income countries through community-based and health service interventionsWHO Document No WHO/EDM/2000 GenevaSwitzerlandWorld Health Organization2002
   Google Scholar
• YusufSTwo decades of progress in preventing cardiovascular diseaseLancet20023602312114031
   PubMed Web of Science ®Google Scholar
• BeagleholeREpping-JordanAPatelVImproving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health careLancet200837294094918790317
   PubMed Web of Science ®Google Scholar
• DeWildeSCareyIMRichardsNWhincupPHCookDGTrends in secondary prevention of ischemic heart disease in the UK 1994–2005 use of individual and combination treatmentHeart200894838817540684
   PubMed Web of Science ®Google Scholar
• NewbyLKLaPointeNMAChenAYLong term adherence to evidence based secondary prevention therapies in coronary artery diseaseCirculation200611320321216401776
   PubMed Web of Science ®Google Scholar
• EUROASPIRE Study GroupEUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease, principal resultsEur Heart J199718156915829347267
   PubMed Web of Science ®Google Scholar
• WoodDAfor the EUROASPIRE GroupClinical realities of coronary prevention: comparison of EUROASPIRE I and II in nine countriesLancet2001357995100111293642
   PubMed Web of Science ®Google Scholar
• KotsevaKWoodDDe BackerGfor EUROASPIRE Study GroupCardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countriesLancet200937392994019286092
   PubMed Web of Science ®Google Scholar
• RogersWTemporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999 The National Registry of Myocardial Infarction 1, 2 and 3J Am Coll Cardiol2000362056206311127441
   PubMed Web of Science ®Google Scholar
• MendisSAbegundeDYusufSWHO study in prevention and recurrence of myocardial infarction and stroke (WHO PREMISE)Bull WHO20058382082816302038
   PubMed Web of Science ®Google Scholar
• KarthikeyanGXavierDPrabhakaranDPaisPPerspectives on the management of coronary artery disease in IndiaHeart2007931334133817933988
   PubMed Web of Science ®Google Scholar
• ChaturvediVBhargavaBHealthcare delivery for coronary heart disease in India: Where are we headedAm Heart Hosp J20075323717268226
   PubMedGoogle Scholar
• GuptaRSecondary prevention of coronary artery disease in urban Indian primary careInt J Cardiol200913518418618620762
   PubMed Web of Science ®Google Scholar
• XavierDPaisPDevereauxPJTreatment and outcomes of acute coronary syndromes in India (CREATE): a prospective registry analysis of registry dataLancet20083711435144218440425
   PubMed Web of Science ®Google Scholar
• Chronic Care Foundation of IndiaNon-communicable Chronic Diseases in India: A study of the gaps, quality and cost of careNew Delhi, IndiaChronic Care Foundation of India200943105
   Google Scholar
• Department of HealthUpdated Version of the QOF Guidance and Evidence BaseLondon, UKDepartment of Health2004
   Google Scholar
• HuninkMGGoldmanLTostesonANThe recent decline in mortality from coronary heart disease 1980–1990. Th effect of secular trends in risk factors and treatmentJAMA19972775355429032159
   PubMed Web of Science ®Google Scholar
• World Health OrganizationPrevention of Cardiovascular Disease Guidelines for risk assessment and management of cardiovascular riskGeneva, SwitzerlandWorld Health Organization2007
   Google Scholar
• The Heart Outcomes Prevention Evaluation Study InvestigatorsEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsN Engl J Med200034214515310639539
   PubMed Web of Science ®Google Scholar
• GuptaRRamipril: the better angiotensin converting enzyme inhibitorIndian Heart J20086018819119240304
   PubMedGoogle Scholar
• GibsonCMNRMI and current treatment patterns for ST-elevation myocardial infarctionAm Heart J20041482933
   PubMed Web of Science ®Google Scholar
• FoxKAGoodmanSGKleinWManagement of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE)Eur Heart J2002231177118912127920
   PubMed Web of Science ®Google Scholar
• GabbayLJLe MayGEvidence-based medicine: do we use guidelines or mindlines?BMJ2004329101315514347
   PubMed Web of Science ®Google Scholar
• AiyarSReforms pay, apathy drags. Sixth state of the states reportIndia Today200833383472
   Google Scholar
• MandelzweigLBattlerABoykoVThe second Euro Heart Survey on acute coronary syndromes: characteristics, treatment and outcome of patients with ACS in Europe and the Mediterranean basin in 2004Eur Heart J2006272285229316908490
   PubMed Web of Science ®Google Scholar
• ReddyKSShahBVargheseCRamadossAResponding to the threat of chronic diseases in IndiaLancet200533617441749
   Google Scholar
• GuptaRPrakashHGuptaRREconomic issues in coronary heart disease prevention in IndiaJ Human Hypertens20051965565715829996
   PubMed Web of Science ®Google Scholar
• GuptaRJoshiPPMohanVReddyKSYusufSEpidemiology and causation of coronary heart disease in IndiaHeart200894162618083949
   PubMed Web of Science ®Google Scholar